Business · 1 sources covering this

GSK India aims to double revenue to ₹8K cr by FY30: MD Bhushan Akshikar

GSK India aims to double revenue to ₹8,000 crore by FY30, with oncology and adult vaccines emerging as key growth drivers alongside its general-medicines portfolio

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·1h ago
GSK India aims to double revenue to ₹8K cr by FY30: MD Bhushan Akshikar
GSK India aims to double revenue to ₹8,000 crore by FY30, with oncology and adult vaccines emerging as key growth drivers alongside its general-medicines portfolio
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/b9d13e49b40251ae0f7f4d9af9e3752953630023"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="GSK India aims to double revenue to ₹8K cr by FY30: MD Bhushan Akshikar"></iframe>

GSK India aims to double revenue to ₹8K cr by FY30: MD Bhushan Akshikar

How 1 sources are covering this

GSK India aims to double revenue to ₹8K cr by FY30: MD Bhushan Akshikar

More from Business

Israel strikes Lebanon again, 11 dead; Iran still defiant on Hormuz control

Russia carries out wave of airstrikes on Ukraine, kills two at steel plant

First time an AI boss fires a human? AI boss Luna fires human employee in ‘first known’ case of its kind – Here's why

UK hospitals unprepared for heat as 'horrific' conditions grip wards

Reader

Trust & legal

Across the network